
Sign up to save your podcasts
Or


Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
By Dr. Neil Love4.4
6363 ratings
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.

134 Listeners

319 Listeners

504 Listeners

31 Listeners

75 Listeners

13 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

44 Listeners

58 Listeners

3,379 Listeners

1,141 Listeners

47 Listeners

367 Listeners

61 Listeners

0 Listeners